NCT01469494

Brief Summary

The Deep Inferior Epigastric Perforator flap (DIEP) is the current standard of care in breast reconstruction. The newer Superficial Inferior Epigastric Artery flap (SIEA) is felt to be an improvement as it does not damage the abdominal wall. The SIEA unfortunately has smaller vessels which put the flap at a higher risk of developing flap loss and fat necrosis. The uncertainty regarding the tradeoffs inherent in the choice of procedure has not been resolved. As such the investigators aim to perform a randomized single blinded trial to evaluate the abdominal and breast related morbidity associated with DIEP and SIEA flaps.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2011

Completed
18 days until next milestone

First Posted

Study publicly available on registry

November 10, 2011

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2012

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

November 6, 2018

Status Verified

August 1, 2014

Enrollment Period

4.8 years

First QC Date

October 23, 2011

Last Update Submit

November 5, 2018

Conditions

Keywords

DIEP flapSIEA flapbreast reconstructionobjective isokinetic abdominal strength testingfat necrosisflap lossseroma rateabdominal wound breakdownBreast-Qabdominal wall outcome questionnaire

Outcome Measures

Primary Outcomes (1)

  • Change in objective isokinetic abdominal strength

    Strength of the abdominal muscles and the back extensors is being objectively measured by isokinetic strength testing on an isokinetic dynamometer (Biodex System III with dual position back extension/flexion attachment). The abdominal strength testing is being performed pre-operatively and at 3, 6 and 12 months post-op. Objective measurements are used to address the strength of the rectus abdominus muscle and all data is collected by personnel at PanAn Clinic who have been trained in the required techniques. The technician performing the assessments is blinded to the type of breast reconstruction that has been performed.

    pre-operative (baseline), 3, 6 and 12 months post-operative

Secondary Outcomes (7)

  • Breast-Q questionnaire

    pre-operative (baseline) and 3 and 12 months post-operative

  • Fat Necrosis

    3 and 6 months post-operative

  • Seroma Rate and Drainage Volumes

    1 week post-op, 2 weeks post-op, 6-8 weeks post-op and 3 months post-op

  • Flap Loss

    1 week post-op, 2 weeks post-op, 6-8 weeks post-op and 3 months post-op

  • Abdominal Wound Breakdown

    1 week post-op, 2 weeks post-op, 6-8 weeks post-op and 3 months post-op

  • +2 more secondary outcomes

Study Arms (2)

DIEP flap group

ACTIVE COMPARATOR

The standard of care for the patient population is the DIEP or SIEA flap breast reconstruction. Currently the single operating surgeon in the study will always try to perform a SIEA flap reconstruction. If the anatomy does not allow it he will convert to a DIEP flap. The majority of breast surgeons in North America will generally perform a DIEP flap initially. The proposed study does not alter the standard of care received.

Procedure: DIEP flap breast reconstruction

SIEA flap group

ACTIVE COMPARATOR

The standard of care for the patient population is the DIEP or SIEA flap breast reconstruction. Currently the single operating surgeon in the study will always try to perform a SIEA flap reconstruction. If the anatomy does not allow it he will convert to a DIEP flap. The majority of breast surgeons in North America will generally perform a DIEP flap initially. The proposed study does not alter the standard of care received.

Procedure: SIEA flap breast reconstruction

Interventions

DIEP stands for deep inferior epigastric perforator. This is the name of the main blood vessel that runs through the abdominal tissue that will be used to reconstruct the breast. In DIEP flap reconstruction, only skin, fat, and blood vessels are removed from the lower belly (the abdomen between the waist and hips). No muscle is removed.

DIEP flap group

The SIEA flap is very similar to the DIEP flap procedure. Both techniques use the lower abdominal skin and fatty tissue to reconstruct a natural, soft breast following mastectomy. The main difference between the SIEA flap and the DIEP flap is the artery used to supply blood flow to the new breast. The SIEA blood vessels are found in the fatty tissue just below skin whereas the DIEP blood vessels run below and within the abdominal muscle (making the surgery more technically challenging). While the surgical preparation is slightly different, both procedures spare the abdominal muscle and only use the patient's skin and fat to reconstruct the breast.

SIEA flap group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female subject older than 18
  • with satisfactory abdominal tissue for DIEP and SIEA flap reconstruction
  • fluent in English

You may not qualify if:

  • reconstruction planned using latissimus dorsi flap, gluteal artery perforator flap or tissue expansion
  • suffer from neurological back problems
  • suffer form inguinal hernias

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences Centre

Winnipeg, Manitoba, R3A 149, Canada

Location

Related Publications (5)

  • Selber JC, Fosnot J, Nelson J, Goldstein J, Bergey M, Sonnad S, Serletti JM. A prospective study comparing the functional impact of SIEA, DIEP, and muscle-sparing free TRAM flaps on the abdominal wall: Part II. Bilateral reconstruction. Plast Reconstr Surg. 2010 Nov;126(5):1438-1453. doi: 10.1097/PRS.0b013e3181ea42ed.

    PMID: 21042100BACKGROUND
  • Selber JC, Nelson J, Fosnot J, Goldstein J, Bergey M, Sonnad SS, Serletti JM. A prospective study comparing the functional impact of SIEA, DIEP, and muscle-sparing free TRAM flaps on the abdominal wall: part I. unilateral reconstruction. Plast Reconstr Surg. 2010 Oct;126(4):1142-1153. doi: 10.1097/PRS.0b013e3181f02520.

    PMID: 20885239BACKGROUND
  • Futter CM, Webster MH, Hagen S, Mitchell SL. A retrospective comparison of abdominal muscle strength following breast reconstruction with a free TRAM or DIEP flap. Br J Plast Surg. 2000 Oct;53(7):578-83. doi: 10.1054/bjps.2000.3427.

    PMID: 11000074BACKGROUND
  • Blondeel N, Vanderstraeten GG, Monstrey SJ, Van Landuyt K, Tonnard P, Lysens R, Boeckx WD, Matton G. The donor site morbidity of free DIEP flaps and free TRAM flaps for breast reconstruction. Br J Plast Surg. 1997 Jul;50(5):322-30. doi: 10.1016/s0007-1226(97)90540-3.

    PMID: 9245865BACKGROUND
  • Bonde CT, Lund H, Fridberg M, Danneskiold-Samsoe B, Elberg JJ. Abdominal strength after breast reconstruction using a free abdominal flap. J Plast Reconstr Aesthet Surg. 2007;60(5):519-23. doi: 10.1016/j.bjps.2006.07.003. Epub 2007 Jan 17.

    PMID: 17399661BACKGROUND

MeSH Terms

Conditions

Fat Necrosis

Condition Hierarchy (Ancestors)

NecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Blair R Peters, BSc

    University of Manitoba Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2011

First Posted

November 10, 2011

Study Start

February 1, 2012

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

November 6, 2018

Record last verified: 2014-08

Locations